C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports
Eur Respir J
.
2020 Apr 16;55(4):1902027.
doi: 10.1183/13993003.02027-2019.
Print 2020 Apr.
Authors
François Parquin
1
,
Elise Cuquemelle
1
,
Eve Camps
2
,
Jérôme Devaquet
3
,
Mathilde Phillips Houllbracq
3
,
Edouard Sage
4
5
,
Olivier Brugière
6
,
Morgan Le Guen
5
7
,
Elisabeth Longchampt
8
,
Stéphanie Malard
9
,
Clément Picard
7
,
Jean Luc Taupin
9
,
Antoine Roux
5
6
;
FOCH Lung Transplant group
Affiliations
1
Thoracic Intensive Care Unit, Foch Hospital, Suresnes, France.
2
Pharmacy Dept, Foch Hospital, Suresnes, France.
3
Intensive Care Unit, Foch Hospital, Suresnes, France.
4
Thoracic Surgery Dept, Foch Hospital, Suresnes, France.
5
Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France.
6
Pneumology, Adult Cystic Fibrosis Center and Lung Transplantation Dept, Foch Hospital, Suresnes, France.
7
Anesthesiology Dept, Foch Hospital, Suresnes, France.
8
Pathology Dept, Foch Hospital, Suresnes, France.
9
Laboratoire Régional d'Histocompatibilité, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
PMID:
32079639
DOI:
10.1183/13993003.02027-2019
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Antibodies
Complement C1 Inhibitor Protein*
Esterases
Graft Rejection / drug therapy
Humans
Lung Transplantation*
Substances
Antibodies
Complement C1 Inhibitor Protein
Esterases